Kohlberg Kravis Roberts & Co »

Biomarin Pharma Inc convertible/ shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $222k 225k 0.98
2023-12-31 $222k 225k 0.99
2023-09-30 $219k 225k 0.97

More positions owned by Kohlberg Kravis Roberts & Co

Bridgebio Pharma (BBIO)
Brightspring Health Svcs
Brightview Holdings (BV)
Jetblue Airways Corp Note 0.500% 4/0 (Principal)
Propertyguru Group Ord Shs (PGRU)
Transphorm (TGAN)
Endeavor Group Hldgs Cl A Com (EDR)
Ncl Corp Note 1.125% 2/1 (Principal)
Kkr Real Estate Finance Trust (KREF)
Fs Kkr Capital Corp (FSK)
Doordash Cl A (DASH)
Marriott Vacations Worldwide Note 1/1 (Principal)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Bausch Health Companies (BHC)
Redfin Corp Note 10/1 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Biomarin Pharma Inc convertible/

Lord, Abbett & Co
Bank of America Corporation
Millennium Management
Citigroup
Aviva
Sona Asset Management
Tenor Capital Management
Shaolin Capital Management
Sunrise Partners Limited Partnership
Partner Fund Management
Moore Capital Management
Thrivent Financial for Lutherans
MacKay Shields
Jpmorgan Chase & Co
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/